Hereditary Spastic Paraplegia (HSP) Panel
$29.00
/
Whole Genome Sequencing 30X
This product is only meant for customers who already purchased a Dante Genome Test
Hereditary Spastic Paraplegia (HSP) is a group of rare genetic disorders that affect the nervous system, leading to progressive stiffness and weakness in the legs. This panel analyzes genes associated with the condition, allowing for early detection and personalized treatment options for patients. The test can benefit individuals with symptoms of spasticity and weakness in the legs, as well as those with a family history of the condition. Early diagnosis can help prevent complications and provide patients and their families with information that can help guide their healthcare decisions.
This panel is recommended for individuals with symptoms of spasticity and weakness in the legs, as well as those with a family history of Hereditary Spastic Paraplegia (HSP). The test can provide patients and their families with information that can help guide their healthcare decisions, including personalized treatment options and the potential for early detection. Early diagnosis can help prevent complications and improve patient outcomes.
The analysis takes into consideration the mutation of germline DNA, it investigates SNP and Indel mutations up to 150 bp.
List of main conditions:
Hereditary Spastic Paraplegia (HSP) is a group of rare genetic disorders that affect the nervous system, leading to progressive stiffness and weakness in the legs. This panel analyzes genes associated with the condition, allowing for early detection and personalized treatment options for patients. The test can benefit individuals with symptoms of spasticity and weakness in the legs, as well as those with a family history of the condition. Early diagnosis can help prevent complications and provide patients and their families with information that can help guide their healthcare decisions.
This panel is recommended for individuals with symptoms of spasticity and weakness in the legs, as well as those with a family history of Hereditary Spastic Paraplegia (HSP). The test can provide patients and their families with information that can help guide their healthcare decisions, including personalized treatment options and the potential for early detection. Early diagnosis can help prevent complications and improve patient outcomes.
The analysis takes into consideration the mutation of germline DNA, it investigates SNP and Indel mutations up to 150 bp.
- Available in less than 24 hours
- Based on Whole Genome Sequencing
- More than 100 genes analyzed
- Investigates SNP and Indel mutations up to 150 bp
List of main conditions:
- Hereditary spastic paraplegia
- Spastic paraplegia type 7
- Spastic paraplegia type 11
- Spastic paraplegia type 15
- Spastic paraplegia type 4
- Spastic paraplegia type 5
- Spastic paraplegia type 31
- Spastic paraplegia type 8
- Spastic paraplegia type 17
- Spastic paraplegia type 3
Our Genomic Panels
Choose a report's category:
Connective Tissue Panel
$29.00
/
Ehlers-Danlos Syndrome Panel
$29.00
/
Cardiovascular Panel
$29.00
/
Autoimmunity Panel
$29.00
/
Gastroenterology Panel
$29.00
/
Dermatology Panel
$29.00
/
Circadian Panel
$29.00
/
ACMG Panel
$29.00
/
Methylation Mechanisms Panel
$29.00
/
Pediatric Panel
$29.00
/
Neurology Panel
$29.00
/
Metabolic Panel
$29.00
/
Endocrinology Panel
$29.00
/
Autism Panel
$29.00
/
Hereditary Cancer Panel
$29.00
/
Oncology Panel
$29.00
/
Neurofibromatosis Panel
$29.00
/
Breast Cancer Panel
$29.00
/
PALB2 Panel
$29.00
/
Our Certifications
